Covered recipient · General Payments record
BRIAN NICHOLS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2023
$874.71
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.15 | 8 |
| Education | $14.29 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $132.04 | 1 |
| RxSight Inc | $57.30 | 2 |
| ABBVIE INC. | $45.70 | 2 |
| Retrophin, Inc. | $37.86 | 2 |
| Genentech USA, Inc. | $23.56 | 1 |
| Alcon Laboratories Inc | $18.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.09 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998012047 | CMS |
| ABBVIE INC. | $29.61 | 08/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998012049 | CMS |
| Alcon Vision LLC | $18.98 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 995799905 | CMS |
| Genentech USA, Inc. | $23.56 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040316777 | CMS |
| Glaukos Corporation | $132.04 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059861833 | CMS |
| RxSight Inc | $20.93 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060180051 | CMS |
| RxSight Inc | $36.37 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060180053 | CMS |
| Travere Therapeutics, Inc. | $14.29 | 06/20/2023 | Education | Undisputed | 01/23/2026 | 1059560317 | CMS |
| Travere Therapeutics, Inc. | $23.57 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059560319 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.